StockDrifts LogoStockDrifts

Perceptive Advisors 13F Portfolio ยท Joseph Edelman

Portfolio Manager
Joseph Edelman
Performance
+24.93% (2026 Q2)
AUM (13F)
$6.66B
# of Holdings
102
Performance Rank
Allocation (Top 20)
65.32%
Latest filing
Q2 2026

Perceptive Advisors LLC Holdings Map

Top 50 Perceptive Advisors LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
PRAX
PRAXIS PRECISION MEDICINES I
10.58%2.04M$681.6M
+0.00%(+0)
2025-Q2: 752.9K shares2025-Q3: 1.56M shares2025-Q4: 2.00M shares2026-Q1: 2.04M shares2026-Q2: 2.04M shares
$79.33(+362.39%)
2026-06-30
SYRE
SPYRE THERAPEUTICS INC
5.95%4.32M$383.5M
+14.17%(+536.27K)
2025-Q2: 1.53M shares2025-Q3: 1.23M shares2025-Q4: 3.07M shares2026-Q1: 3.78M shares2026-Q2: 4.32M shares
$31.14(+232.82%)
2026-06-30
CELC
CELCUITY INC
5.19%3.20M$334.5M
+2.24%(+70.00K)
2025-Q2: 1.63M shares2025-Q3: 2.96M shares2025-Q4: 3.16M shares2026-Q1: 3.13M shares2026-Q2: 3.20M shares
$29.94(+207.33%)
2026-06-30
RYTM
RHYTHM PHARMACEUTICALS INC
4.46%2.59M$287.2M
+8.95%(+212.50K)
2025-Q2: 2.42M shares2025-Q3: 419.10M shares2025-Q4: 2.55M shares2026-Q1: 2.37M shares2026-Q2: 2.59M shares
$82.84(+39.40%)
2026-06-30
ROIV
ROIVANT SCIENCES LTD
4.44%8.09M$286.1M
-2.41%(-200.00K)
2025-Q2: 3.33M shares2025-Q3: 7.37M shares2025-Q4: 7.99M shares2026-Q1: 8.29M shares2026-Q2: 8.09M shares
$12.69(+185.29%)
2026-06-30
RLAY
RELAY THERAPEUTICS INC
4.1%14.11M$263.9M
+44.66%(+4.36M)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 1.90M shares2026-Q1: 9.75M shares2026-Q2: 14.11M shares
$10.38(+91.41%)
2026-06-30
TVTX
TRAVERE THERAPEUTICS INC
3.31%3.75M$213.2M
-9.41%(-389.98K)
2025-Q2: 834.3K shares2025-Q3: 3.79M shares2025-Q4: 4.28M shares2026-Q1: 4.14M shares2026-Q2: 3.75M shares
$20.13(+208.72%)
2026-06-30
NUVL
NUVALENT INC
3.03%1.58M$195.2M
+0.00%(+0)
2025-Q2: 1.38M shares2025-Q3: 1.56M shares2025-Q4: 1.67M shares2026-Q1: 1.58M shares2026-Q2: 1.58M shares
$45.99(+169.55%)
2026-06-30
EWTX
EDGEWISE THERAPEUTICS INC
2.76%4.37M$177.7M
-1.13%(-50.00K)
2025-Q2: 4.64M shares2025-Q3: 3.80M shares2025-Q4: 4.46M shares2026-Q1: 4.42M shares2026-Q2: 4.37M shares
$21.05(+109.85%)
2026-06-30
APGE
APOGEE THERAPEUTICS INC
2.7%1.31M$173.6M
-15.08%(-232.27K)
2025-Q2: 1.18M shares2025-Q3: 1.35M shares2025-Q4: 2.33M shares2026-Q1: 1.54M shares2026-Q2: 1.31M shares
$40.78(+229.96%)
2026-06-30

About Perceptive Advisors LLCโ€™s portfolio

Perceptive Advisors LLC reports $6.66B in US-listed equity holdings across 102 positions in its most recent 13F filing. Its largest disclosed positions are PRAX (10.6%), SYRE (6.0%) and CELC (5.2%). The top 20 holdings account for 65.32% of reported assets. Its disclosed equity book has returned +137.68% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
PRAX โ€” 12.6% ($681.63M)SYRE โ€” 7.1% ($383.48M)CELC โ€” 6.2% ($334.49M)RYTM โ€” 5.3% ($287.16M)ROIV โ€” 5.3% ($286.14M)RLAY โ€” 4.9% ($263.93M)TVTX โ€” 3.9% ($213.18M)NUVL โ€” 3.6% ($195.19M)EWTX โ€” 3.3% ($177.71M)APGE โ€” 3.2% ($173.63M)Other โ€” 44.7% ($2.43B)
55%in top 10
  • PRAX12.6%
  • SYRE7.1%
  • CELC6.2%
  • RYTM5.3%
  • ROIV5.3%
  • RLAY4.9%
  • TVTX3.9%
  • NUVL3.6%
  • EWTX3.3%
  • APGE3.2%
  • Other44.7%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
4
BIIBBIOGEN INC0.9%
UNHUNITEDHEALTH GROUP INC0.8%
CRLCHARLES RIV LABS INTL INC0.5%
DHRDANAHER CORP DEL0.4%
Added to
25
RLAYRELAY THERAPEUTICS INC+44.7%
TNGXTANGO THERAPEUTICS INC+317.9%
RVMDREVOLUTION MEDICINES INC+104.0%
SYRESPYRE THERAPEUTICS INC+14.2%
+21 more
Trimmed
13
DYNDYNE THERAPEUTICS INC-42.4%
APGEAPOGEE THERAPEUTICS INC-15.1%
PTGXPROTAGONIST THERAPEUTICS INC-20.2%
TVTXTRAVERE THERAPEUTICS INC-9.4%
+9 more

Unlock alerts, watchlists & AI chat

Sign up free to track Perceptive Advisors LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Perceptive Advisors LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1224962). View Perceptive Advisors LLCโ€™s 13F filings on SEC

More 13F analyses

View all